LINCOLNBSELincoln Pharmaceuticals LtdMinimalNeutral
Announced Fri, 29 May · 15:04 IST

We enclosed herewith the copies of published newspaper advertisement with respect to Audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Year ended March 31, 2026.

LINCOLN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-20.9%1-day move
₹760.00
prior close
₹637.95
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.6-0.2-0.7-20.9-22.4-22.9-18.0-18.0-16.4-19.2-17.5
Up moveDown movePending
AI summary

Lincoln Pharmaceuticals has informed stock exchanges that newspaper advertisements for its audited standalone and consolidated financial results for Q4 and the financial year ended March 31, 2026 were published on May 28, 2026 in Financial Express (English and Gujarati). The Board of Directors meeting held on May 28, 2026 approved these results. The full financial results along with the auditor's report are available on the company's website (www.lincolnpharma.com/investor/) and on BSE/NSE websites. This filing complies with SEBI Listing Regulations (Regulation 47).

Likely market impact

This is a procedural filing confirming public disclosure of audited annual results. The actual financial figures were not included in this advertisement notice — investors should refer to the detailed results filing for performance data. The company operates in the pharmaceutical sector.